Liansheng Su is a notable inventor based in Winchester, MA, who has made significant contributions to the field of pharmaceuticals. With a total of four patents to his name, he has focused on developing innovative compounds that address various medical conditions.

Latest Patents

Among his latest patents is a groundbreaking work on hydroquinazoline derivatives for the treatment of diseases or disorders. This patent discloses a compound of Formula (I) or a pharmaceutically acceptable salt thereof, with specific structural components described in detail. Another significant patent involves cyclic tetramer compounds that act as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors. This invention is particularly relevant for treating metabolic disorders and cholesterol lipid metabolism, featuring a complex formula that includes various structural elements.

Career Highlights

Liansheng Su is currently associated with Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to contribute to the development of innovative therapies that can improve patient outcomes.

Collaborations

Throughout his career, Liansheng has collaborated with talented individuals such as Justin Yik Ching Mao and Tajesh Jayprakash Patel. These collaborations have further enhanced the impact of his research and inventions.

Conclusion

Liansheng Su's innovative work in the pharmaceutical field, particularly in developing new compounds for treating various disorders, showcases his dedication to advancing medical science. His contributions continue to influence the industry and improve healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.